Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Is Goodman buying?

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Aug 16, 2023 7:49pm

88 Views

Post# 35592024

RE:Is Goodman buying?

and evertime for the past six years or so that MNGT, BOD and GUD has bought more shares they have lost money. Madness is when you keep doing or say the same thing and expect different results

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec